Countable Labs and Promega Announce Co-Marketing Agreement to Facilitate End-to End Biological Sample Preparation and Rare Variant Detection

Countable Labs and Promega announce co-marketing agreement to facilitate end-to end biological sample preparation and rare variant detection.
News Medical

Automated magnetic bead technology for high-throughput viral nucleic acid isolation

Viral diseases pose a significant global health challenge, placing substantial strain on healthcare systems. Accurate identification of viral infections is crucial for monitoring outbreaks, managing ...
GEN

DNA‑Guided CRISPR Suggests a New Direction for RNA Editing

CRISPR’s rise from obscure bacterial defense system to molecular scalpel has always hinged on one small component: the guide RNA. For years, that guide RNA—meticulously designed, modified, and ...
The Conversation

RNA has newly identified role: Repairing serious DNA damage to maintain the genome

Your DNA is continually damaged by sources both inside and outside your body. One especially severe form of damage called a double-strand break involves the severing of both strands of the DNA double ...
Pharmabiz

Countable Labs inks agreement with Promega to facilitate biological sample preparation and rare variant detection

Countable Labs inks agreement with Promega to facilitate biological sample preparation and rare variant detection: Palo Alto, California Monday, June 29, 2026, 16:00 Hrs [IST] Cou ...